Rachael Sirianni, PhD, earned her undergraduate degree in bioengineering at Arizona State University (ASU) in 2003 and her doctorate in biomedical engineering at Yale University in 2008. She completed a postdoctoral fellowship in diagnostic radiology at the Yale School of Medicine in 2011, at which point she joined the Barrow Brain Tumor Research Center as principal investigator in the Laboratory for Nanomedicine.Dr. Sirianni has an interdisciplinary background, having published journal articles in the fields of polymeric drug delivery, neurobiology, imaging, and neuro-oncology. She was the recipient of several competitive awards, including a predoctoral NIH training grant (2006-2008), a postdoctoral NIH training grant (2008-2011), multiple travel awards to national and international conferences, and a young investigator award from the Biomedical Engineering Society. Dr. Sirianni holds adjunct positions in the biomedical engineering and chemical engineering departments at ASU. Her research program at Barrow is driven by the translational goal of identifying more effective drug therapies for the treatment of central nervous system disorders. 

cns targeted drug delivery, tissue engineering of tumor microenvironment, central nervous system disorders